India's IPO market soars, but mega deals aren't always safe bets—research before investing in the next big IPO.

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other ...

After a record 2025 with 373 listings raising ₹1.95 trillion, primary market activity slows sharply as subscriptions moderate, small- and mid-cap weakness weighs on sentiment, and analysts flag a ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range. The initial public offering has drawn orders for about 10 times the number of shares ...

India’s primary market is beginning to show signs of fatigue after a strong run in 2025, with the recent IPOs of Aye Finance and Clean Max Enviro Energy Solutions failing to fully subscribe, ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Medline seeks as much as $5.37 billion in New York IPO Blockbuster share sale comes as 2025 IPO market enters final stretch Cornerstone investors set to buy up to $2.35 billion worth of Medline shares ...

Average listing gains have slumped to just 8.88% in FY26 (as of mid-February), with only about 65% of IPOs managing to list above their issue price. India’s primary market is witnessing a striking ...